Back
NovaBay Pharmaceuticals Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
45
NBY
NovaBay Pharmaceuticals
Last Price:
0.77
Seasonality Move:
-8.12%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight buying pressure.
NovaBay Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.69 | Buy |
| 20-day SMA: | 0.64 | Buy |
| 50-day SMA: | 0.6 | Buy |
| 200-day SMA: | 2.64 | Sell |
| 8-day EMA: | 0.71 | Buy |
| 20-day EMA: | 0.67 | Buy |
| 50-day EMA: | 0.75 | Buy |
| 200-day EMA: | 6.24 | Sell |
NovaBay Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 62.96 | Buy |
| Chaikin Money Flow: | -5249 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.59 - 0.73) | Buy |
| Bollinger Bands (100): | (0.3 - 1.8) | Sell |
NovaBay Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovaBay Pharmaceuticals Stock
Is NovaBay Pharmaceuticals Stock a Buy?
- NovaBay Pharmaceuticals share price is 0.76 while NBY 8-day simple moving average is 0.69, which is a Buy signal.
- The stock price of NBY is 0.76 while NovaBay Pharmaceuticals 20-day SMA is 0.64, which makes it a Buy.
- NovaBay Pharmaceuticals 50-day simple moving average is 0.60 while NBY share price is 0.76, making it a Buy technically.
- NBY stock price is 0.76 and NovaBay Pharmaceuticals 200-day simple moving average is 2.64, creating a Sell signal.
NBY Technical Analysis vs Fundamental Analysis
Sell
45
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy or a Sell?
-
NovaBay Pharmaceuticals stock is rated a Sell
The current NovaBay Pharmaceuticals [NBY] share price is $0.76. The Score for NBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
NovaBay Pharmaceuticals Stock Info
Market Cap:
3.69M
Price in USD:
0.76
Share Volume:
148.19K
NovaBay Pharmaceuticals 52-Week Range
52-Week High:
12.77
52-Week Low:
0.36
Sell
45
NovaBay Pharmaceuticals (NBY)
is a Sell
NovaBay Pharmaceuticals Share Price Forecast
-
What is the NovaBay Pharmaceuticals stock price today?
The NovaBay Pharmaceuticals stock price is 0.76 USD today. -
Will NBY stock go up or go down?
NovaBay Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is NovaBay Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovaBay Pharmaceuticals is overvalued.
Is NovaBay Pharmaceuticals Stock a Buy?
- NovaBay Pharmaceuticals share price is 0.76 while NBY 8-day exponential moving average is 0.71, which is a Buy signal.
- The stock price of NBY is 0.76 while NovaBay Pharmaceuticals 20-day EMA is 0.67, which makes it a Buy.
- NovaBay Pharmaceuticals 50-day exponential moving average is 0.75 while NBY share price is 0.76, making it a Buy technically.
- NBY stock price is 0.76 and NovaBay Pharmaceuticals 200-day simple moving average is 6.24, creating a Sell signal.
Fundamental Analysis of NovaBay Pharmaceuticals
Is NovaBay Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Technical Analysis of NovaBay Pharmaceuticals
Should I short NovaBay Pharmaceuticals stock?
- NBY Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting NovaBay Pharmaceuticals is a Buy
- NovaBay Pharmaceuticals Relative Strength Index (RSI) is 62.96, which suggest NovaBay Pharmaceuticals is overbought
- The Bollinger Bands (25) for NovaBay Pharmaceuticals is (0.59 - 0.73), which suggest NovaBay Pharmaceuticals is a Sell
- The Bollinger Bands (100) for NovaBay Pharmaceuticals is (0.3 - 1.8), which suggest NovaBay Pharmaceuticals is a Sell
* NovaBay Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.